Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04533685 · ClinicalTrials.gov registry record · NA

Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
213,773
Enrollment target

NCT04533685 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 213,773 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04533685, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
213,773 participants
Enrollment target

Study Summary

This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a 2x2x2 factorial design, nested in a parallel 2-arm trial. The parallel arms are control v. reminder letter (reminder messages sent via the patient portal, reminding participants of an overdue influenza vaccine) Nested within the reminder letter arm, we will have 3 additional components: * A direct scheduling link within the reminder letter enabling the patient to schedule an influenza vaccine only visit (direct scheduling link vs. no direct scheduling link). * A pre-commitment prompt (pre-commitment prompt vs. no prompt) asking about a patient's intention to get the influenza vaccination * A pre-appointment reminder, encouraging patients to ask for their influenza vaccine at their upcoming appointment (pre-appointment reminder encouraging influenza vaccination vs. standard pre-appointment reminder not mentioning influenza vaccination)

Interventions

  • BEHAVIORAL Portal Reminders for Influenza Vaccination: Direct scheduling link
  • BEHAVIORAL Portal Reminders for Influenza Vaccination: No direct scheduling link
  • BEHAVIORAL Pre-Commitment Prompt
  • BEHAVIORAL Pre-Appointment flu vaccine reminders

Trial Details

FieldValue
Enrollment Target 213,773 participants
Start Date 2020-09-01
Est. Completion 2021-04-01
Phase NA

What the Registry Record Tells You About NCT04533685

The ClinicalTrials.gov registry entry for NCT04533685 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213,773 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Portal Reminders for Influenza Vaccination: Direct scheduling link is the first listed.

NCT04533685 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04533685 about?

NCT04533685 is a clinical study titled "Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3". This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a 2x2x2 factorial design, nested in a parallel 2-arm trial. The parallel arms are control v. reminder letter (reminder messages sent via the patient portal, re...

What is the current status of trial NCT04533685?

This trial is currently completed. It is a NA study. The enrollment target is 213,773 participants. The study started on 2020-09-01. Estimated completion is 2021-04-01.

What interventions are being tested in trial NCT04533685?

The interventions under investigation include: Portal Reminders for Influenza Vaccination: Direct scheduling link (BEHAVIORAL), Portal Reminders for Influenza Vaccination: No direct scheduling link (BEHAVIORAL), Pre-Commitment Prompt (BEHAVIORAL), Pre-Appointment flu vaccine reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT04533685?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.